Navigation Links
Top Spin Appoints Yaron Tal President and Chief Executive Officer, Erez Golan, TopSpin Medical's Founder and Current Chief Executive Officer, Will Continue as a Board Member and Consultant
Date:10/4/2007

TEL AVIV, Israel, October 4 /PRNewswire-FirstCall/ -- TopSpin Medical (TASE: TOPMD), the developer of a unique technology for high-resolution MRI using an IntraVascular MRI (IVMRI) catheter for the coronary arteries, announced today the appointment of Yaron Tal as President and Chief Executive Officer. Yaron Tal will be replacing Erez Golan who will continue to serve as a board member and consultant to the company.

Mr. Golan founded Topspin in 1999, and has led the company from the initial development stage. During this time period, Mr. Golan spearheaded the development of the company's unique core MRI technology and its first cardiology product, obtaining CE mark, establishment of clinical infrastructure, initial distribution agreements in Europe as well as completion of data collection required for the FDA submission.

Mr. Tal joins Topspin Medical from Galil Medical, a global medical device company whose cryotherapy systems for Urology, Gynecology and Radiology related diseases were sold in 2006 for double-digit million dollars, where he held the position of President & Chief Executive Officer for the last 4 years. Prior to joining Galil Medical, Mr. Tal served as CFO and acting manager of DEP technology holding Ltd, the investment arm of Elron Electronic Industries Ltd and Discount investments Corporation Ltd. Mr. Tal began his professional career in the offices of Prof . Swary - Itzhak Swary & Co financial consulting - and has since accumulated significant experience in mergers and acquisitions.

Mr. Golan, TopSpin's CEO, commented: "Topspin has been my life work for almost a decade. I founded the company and lead it from its inception. After 8 intensive years of hard work and accomplishments, today Topspin is a mature company ready to take the next step. I feel that this is the right time for new forces to join ranks and I wish all the best to my successor Mr. Yaron Tal"

Mike Berman, Topspin's Chairman of the Board said: "Topspin is well positioned for our next stage. Erez's decision to embark on a new direction was made following lengthy and constructive discussion with the Board. I would like to wish Yaron Tal success in his new role; Yaron's extensive experience in managing medical device companies makes him the best candidate to lead Topspin to our next phase".

Mr. Tal said: "I'm proud to join the Topspin team as its new CEO. The unique platform technology will enable us to become a market leader in different imaging applications. I believe that the combination of technological breakthrough, long term vision and professional experienced team are the formula for success. I would like to thank Erez for his contribution to the company, and look forward to leading the company to further success."

About TopSpin

TopSpin Medical developed an innovative and unique technology for high-resolution MRI using an IntraVascular MRI (IVMRI) catheter for the coronary arteries, without the need for an expensive and bulky external MRI setup. The catheter contains those components, which are usually found in a conventional MRI scanner, only that they are miniaturized to less than 2 millimeters in size. In 2006 TopSpin Medical began to develop its technology for imaging prostate cancer by an integrated endo-rectal MRI and ultrasound probe.

Statements in this press release which are not historical data are forward-looking statements which involve known and unknown risks, uncertainties or other factors not under the company's control, which may cause actual results, performance or achievements of the company to be materially different from the results, performance or other expectations implied by these forward-looking statements. These factors include, but are not limited to, those detailed in the company's periodic filings with the securities authorities.

* Caution: TopSpin IVMRI system is not available for sale in the United States.

Contact:

Eyal Kolka

CFO & Senior Vice President

Business Development

+972-8-920-0033

eyal@topspin.co.il


'/>"/>
SOURCE TopSpin Medical Israel Ltd
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Sharon Ethanol appoints operations director
2. Kyron appoints former AMA chairman to board
3. Brady appoints GE efficiency expert as CTO
4. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
5. Johnson Controls appoints Roell to head EOC
6. SecurePipe appoints two senior execs
7. Milwaukees PointOne appoints new president and CEO
8. Third Wave appoints new chairman
9. Midwest Venture Summit disappoints; Cato grades Midwest governors
10. Sonic Foundry appoints Engineering Dean and Cometa CEO to Board of Directors
11. TeraMEDICA Appoints Prekop as New President
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... 23, 2017 In today,s pre-market ... in the Biotech industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), ... MKT: SYN), and Regulus Therapeutics Inc. (NASDAQ: ... Credit Suisse upgraded its rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." ... report at: ...
(Date:3/22/2017)... , March 22, 2017  UBM and ... to announce their extended partnership and the third ... headlined by the 21 st Annual MassMEDIC ... taking place May 3-4, 2017. ... Technology Association (ADVAMED) President and CEO, Scott ...
(Date:3/22/2017)... , March 22, 2017 MarketNewsUpdates.com ... ... cancer conditions are being pressured as of late due to ... cancer pain management has a dramatic impact on patient,s quality ... and development activities for identifying new forms of opioid formulations ...
(Date:3/22/2017)... ... March 21, 2017 , ... Okyanos Cell Therapy has announced Tallahassee, FL ... live events series, “Stem Cell Therapy: The Next Phase in the Evolution of Medicine.” ... Stem Cell Research and Therapy Act, Okyanos maintains a mission to help “no-option” ...
Breaking Biology Technology:
(Date:2/16/2017)... 2017  Genos, a community for personal genetic ... received Laboratory Accreditation from the College of American ... laboratories that meet stringent requirements around quality, accuracy ... "Genos is committed to maintaining the ... honored to be receiving CAP accreditation," said ...
(Date:2/10/2017)... Feb 10, 2017 Research and ... "Personalized Medicine - Scientific and Commercial Aspects" to ... ... Diagnosis is integrated with therapy for selection of treatment as ... detection and prevention of disease in modern medicine. Biochip/microarray technologies ...
(Date:2/8/2017)... 2017 Report Highlights ... The global synthetic-biology market reached nearly ... 2021, growing at a compound annual growth rate (CAGR) of ... the global markets for synthetic biology. - Analyses of global ... projections of compound annual growth rates (CAGRs) through 2021. - ...
Breaking Biology News(10 mins):